Xin Lang Cai Jing·2026-02-24 01:56Core Viewpoint - The domestic brain-computer interface (BCI) industry is expected to enter a significant phase with the upcoming application for market registration of the first domestically produced implantable BCI product, driven by a combination of policy, capital, and technological advancements [3][22]. Industry Overview - The BCI technology is entering its 3.0 era, characterized by the deep integration of perception, stimulation, and control. The industry is moving towards a breakthrough phase, with both invasive and non-invasive categories being developed [4][23]. - The invasive BCI segment includes full-intrusive, semi-intrusive, and interventional types, with domestic manufacturers making progress in clinical applications [4][27]. - The non-invasive segment is also advancing, with companies preparing for product registrations and commercial launches [4][12]. Investment Opportunities - Three main investment themes have been identified: 1. Leading companies in the invasive sector that achieve technological breakthroughs or excellent clinical results [17][22]. 2. Leading companies in the non-invasive sector with diverse application scenarios and strong commercialization capabilities [17][22]. 3. Leading companies with advanced CDMO/CRO capabilities [17][22]. Market Projections - The domestic BCI medical market is projected to reach nearly 50 billion yuan by 2035, indicating significant growth potential for leading companies in the midstream sector [8][27]. - The overall market size for invasive and non-invasive BCIs is expected to grow substantially, with estimates indicating a total market size of 456.2 billion yuan by 2035 [29]. Technological Developments - Key components such as electrodes and chips are critical for BCI systems, with domestic manufacturers making strides in self-research and development. The focus is on improving signal quality and biocompatibility [8][27]. - The software side, particularly signal decoding algorithms, relies on clinical data accumulation, which domestic companies are expected to leverage for competitive advantage [8][27]. Policy Support - The Chinese government has been actively supporting the BCI industry through various policies, including approval processes for innovative devices, insurance pricing standards, and ethical guidelines [12][33]. - Recent policies have emphasized the importance of clinical translation and the establishment of industry standards, which are crucial for the advancement of BCI technologies [12][33].